Рет қаралды 881
In the 1st video of this 6 part "SUMMIT SUPERCUTS" video series about Periodic Paralysis, Dr. Steve Cannon discusses repurposing a current known drug, Retigabine, (used to treat epilepsy) for use in preventing attacks of periodic paralysis. Dr. Cannon discusses a generalized summary of PP, channelopathies, Retigabine and why it may be used to treat attacks of PP. This presentation was filmed at the annual PPA Conference in Orlando, Florida along with 5 other discussions about PP. If this discussion was insightful, you might find the other talks in this series helpful as well.
You can watch all 6 Summit Supercuts from the 2021 PPA Conference here:
Summit Supercut 1 - Repurposing A Drug for Preventing Attacks of PP : Watching
Summit Supercut 2 - Safe Anesthesia for Periodic Paralysis Patients : • Safe Anesthesia for Pe...
Summit Supercut 3 - Family Genetics Finds SCNA4A Variant Defect : • Family Genetic Testing...
Summit Supercut 4 - Paramyotonia Congenita: • Paramyotonia Congenita...
Summit Supercut 5 - CRSPR Gene Editing for PP Patients : • CRISPR Editing for Rar...
Summit Supercut 6 - Andersen-Tawil Syndrome (ATS) : • Andersen Tawil Syndrom...
#PeriodicParalysis #Prevention #PPA
Periodic Paralysis is an extremely rare disease and you may have a lot of questions, a great resource to help find answers can be found at the PPA website at www.periodicpa...
We'd love to hear from you. Comment below on your experience with PP or with questions about the condition.
You can also donate at
www.periodicpa...
Your donation will help with Dr. Cannon's genetic research or a list of other extremely helpful options. The great thing is you can decide how you want your donation to be used.
________________________________________
Connect with us on social:
Facebook: / periodicparalysisassoc...
Instagram: / periodicparalysis
________________________________________
If you liked this video, please hit the like button, subscribe to our channel and hit the bell button to receive future videos.
#PPA #NotFaking #paralyzed
________________________________________